To facilitate the laboratory diagnosis of human cases of pythiosis insidiosi, an immunological test was evaluated. A soluble antigen was prepared from a human isolate of Pythium insidiosum, an aquatic, thermotolerant oomycete that causes infections in cattle, dogs, horses, and humans. Sera from seven proven cases of disseminated human pythiosis insidiosi were tested in an immunodiffusion test along with appropriate control sera from patients with a variety of actinomycotic, bacterial, and mycotic diseases as well as sera from uninfected individuals. Titers ranged from 1:1 to 1:32 in the seven serum samples from the disseminated cases of pythiosis insidiosi of varying severity. The heterologous sera gave negative reactions. The rapidity and specificity of the immunodiffusion test makes it a useful diagnostic tool for the serodiagnosis of P. insidiosum infections.
Human cases of pythiosis insidiosi were first described as a new disease entity in 1989 in patients from Thailand (1, 5, 6) . The disease is caused by Pythium insidiosum, an aquatic oomycete that produces bifiagellate zoospores. The clinical features and signs of pythiosis insidiosi in humans are characterized by chronicity and progressive arterial insufficiency folloWed by the development of gangrene, aneurysms, and at times, fatal arterial leakage. The subcutaneous form -is slowly progressive and nonfatal. The disease syndrome was found among farmers who had thalassemia hemoglobinopathy syndrome as a possible risk factor. Isolation and identification of P. insidiosum is difficult. Serodiagnosis by means of a serological test would be a useful tool for diagnosis, as described by Mendoza et al. (3) , who used a soluble antigen for diagnosing and monitoring pythiosis insidiosi in horses. The objective of this study was to determine whether this test could be similarly used for the diagnosis of human cases of this disease and whether decreasing titers could be used to monitor the disease.
Sera from seven farmers with clinical features of leg gangrene were collected during the active phase of their infection, prior to surgical treatment, and were collected serially thereafter. These seven patients had histological proof of mycotic arteritis at the site of their arterial occlusions. The morphology of the hyphae in their tissues was consistent with that of P. insidiosum, i.e., broad, rarely septate hyphae with right-angle branching. Only three of the patients were culture positive. Although the morphology of the hyphae was not unique for P. insidiosum, the unique clinical features and pathology make this diagnosis highly probable, so we included them in our series. In addition, two serum samples from farmers with culture-proven pythiosis insidiosi of the eye were also studied. Control sera were collected from 20 patients with other culture-proven infec-* Corresponding author. , and melioidosis (Pseudomonas pseudomallei; n = 6). Serum samples from 15 uninfected thalassemic farmers and 14 healthy blood donors were also included as controls. All sera were frozen at -20°C until they were tested.
For antigen production, a culture filtrate antigen was prepared by the method described by Mendoza et al. (4) . P. insidiosùm F-RTCC 1472 obtained from an aneurysm in a human case of pythiosis insidiosi, which was confirmed at the Centers for Disease Control, Atlanta, Ga., was used as a reference strain for preparing our antigen. The isolate was subcultured on Sabouraud dextrose agar (Difco Laboratories, Detroit, Mich.) and was incubated at 25°C for 3 days. A small portion of the growth was transferred to each of three flasks containing 500 ml of brain heart infusion broth, and the flasks were incubated at 37°C for 1 month. The mycelium was killed by storage at 4°C for 1 week. The supernatant from the broth cultures was separated and concentrated 20-fold with polyvinyl pyrrolidone (BDH, Poole, England).
This soluble antigen was used in the immunodiffusion (ID) tests.
In the ID test, agar gel diffusion was carried out on a slide which contained 7 ml of 1% purified agar in Veronal buffer (pH 7.8). The antigen and antibody were added to 4-mmdiameter wells which were 4 mm apart. The slides were then incubated in a humid chamber at room temperature for 24 h. Positive sera were subjected to serial twofold dilutions and were retested for antibody titers in a similar way.
Seven serum samples, which were collected at the time of active infection before surgical treatment, were positive in the ID test, with titers ranging from 1:1 to 1:32. Serum samples from the two patients with ocular pythiosis insidiosi and from 20 patients with bacterial and fungal infections other than pythiosis insidiosi and 29 control serum samples were all negative. The antibody titers of the sera from the seven cases of pythiosis insidiosi, which were originally antibody positive, were serially determined, as shown in Table 1 . A significant decrease in the antibody titer (greater than fourfold) was observed in cases 1 to 5. This appeared to correlate well with clinical improvement after surgical treatment. The follow-up of these five cases over a 2-to 12-month period revealed no signs or symptoms of relapse. One patient (case 6), who had rising and persistent antibody titers, subsequently died as a result of progressive infection. The last case (number 7) had an initial failure following surgical removal and further resection of the infected arteritis. This patient had no significant decrease in antibody titer, but his followup was lost. Retesting of these antisera with another soluble antigen, which was kindly provided by P. Imwidthaya from the Siriraj Hospital in Bangkok, showed the reproducibility of the test; the antibody titers varied only within one dilution.
Pythiosis insidiosi arteritis in humans has rarely been reported in the literature (5 (3) . Considering that the clinical course of oomycotic arteritis is gradually progressive and mainly silent (5), this test not only will be useful for the early diagnosis of P. insidiosum infection but may very well serve as an indicator of treatment failure, which would alert physicians of the need to reevaluate their treatment procedure.
No antibody was detected in sera from two patients who had ocular pythiosis insidiosi. The corneal infections may have been inaccessible to their immunological defense mechanisms. This may explain the negative serology in these patients.
In conclusion, we demonstrated that the ID test for antibody to P. insidiosum is a sensitive and specific test to help in diagnosing Pythium arterites and in monitoring the activity of the disease.
